Cargando…

Endoscopic Bariatric Treatment with Duodenal-Jejunal Bypass Liner Improves Non-invasive Markers of Non-alcoholic Steatohepatitis

PURPOSE: People with obesity often develop non-alcoholic fatty liver disease (NAFLD) and are at high risk of progression to non-alcoholic steatohepatitis (NASH). Few therapies are effective other than bariatric surgery. We therefore analyzed data from duodenal-jejunal bypass liner (DJBL) patients re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karlas, Thomas, Petroff, David, Feisthammel, Jürgen, Beer, Sebastian, Blüher, Matthias, Schütz, Tatjana, Lichtinghagen, Ralf, Hoffmeister, Albrecht, Wiegand, Johannes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Original Contributions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273553/ https://www.ncbi.nlm.nih.gov/pubmed/35713854 http://dx.doi.org/10.1007/s11695-022-06150-5

Ejemplares similares

Design of the Weight-loss Endoscopy Trial (WET): a multi-center, randomized, controlled trial comparing weight loss in endoscopically implanted duodenal-jejunal bypass liners vs. intragastric balloons vs. a sham procedure
por: Hollenbach, Marcus, et al.
Publicado: (2018)

The EndoBarrier: Duodenal-Jejunal Bypass Liner for Diabetes and Weight Loss
por: Ruban, Aruchuna, et al.
Publicado: (2018)

Research Progress of Duodenal-Jejunal Bypass Liner in the Treatment of Obesity and Type 2 Diabetes Mellitus
por: Chen, Ji-Hua, et al.
Publicado: (2022)

Is duodeno-jejunal bypass liner superior to pylorus preserving bariatric surgery in terms of complications and efficacy?
por: Balint, Istvan Bence, et al.
Publicado: (2021)

A Preclinical Animal Study of Combined Intragastric Balloon and Duodenal-Jejunal Bypass Liner for Obesity and Metabolic Disease
por: Ghoz, Hassan, et al.
Publicado: (2020)

Effects of duodenal–jejunal bypass surgery in ameliorating nonalcoholic steatohepatitis in diet-induced obese rats
por: Yu, Hsin-Hsien, et al.
Publicado: (2019)

Duodenal-Jejunal Bypass Liner for the management of Type 2 Diabetes Mellitus and Obesity: A Multicenter Randomized Controlled Trial
por: Ruban, Aruchuna, et al.
Publicado: (2022)

Non-invasive assessment of steatohepatitis indicates increased risk of coronary artery disease
por: Beer, Sebastian, et al.
Publicado: (2023)

Concurrent Placements of a Duodenal-Jejunal Bypass Liner and an Intragastric Balloon Among Severely Obese Patients: A Case Series
por: Sartoretto, Adrian, et al.
Publicado: (2019)

Clinical follow-up on weight loss, glycemic control, and safety aspects of 24 months of duodenal-jejunal bypass liner implantation
por: Betzel, B., et al.
Publicado: (2019)

Duodenal-jejunal bypass liner implantation provokes rapid weight loss and improved glycemic control, accompanied by elevated fasting ghrelin levels
por: Koehestanie, Parweez, et al.
Publicado: (2014)

The Effect of 6 and 12 months Duodenal-Jejunal Bypass Liner Treatment on Obesity and Type 2 Diabetes: a Crossover Cohort Study
por: van Rijn, Selwyn, et al.
Publicado: (2017)

Does Bypass of the Proximal Small Intestine Impact Food Intake, Preference, and Taste Function in Humans? An Experimental Medicine Study Using the Duodenal-Jejunal Bypass Liner
por: Aldhwayan, Madhawi M., et al.
Publicado: (2022)

Feasibility of a new bariatric fully endoscopic duodenal-jejunal bypass: a pilot study in adult obese pigs
por: Gonzalez, Jean-Michel, et al.
Publicado: (2022)

Preoperative Upper-GI Endoscopy Prior to Bariatric Surgery: Essential or Optional?
por: Moulla, Yusef, et al.
Publicado: (2020)

Effect of duodenal-jejunal bypass on diabetes in the early postoperative period
por: Okikawa, Shohei, et al.
Publicado: (2023)

Duodenal‐jejunal bypass liner for the treatment of type 2 diabetes and obesity: 3‐year outcomes in the First National Health Service (NHS) EndoBarrier Service
por: Ryder, Robert E. J., et al.
Publicado: (2022)

Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide
por: Ryder, Robert E.J., et al.
Publicado: (2023)

Sustained weight loss after duodenal–jejunal bypass liner treatment in patients with body mass index below, but not above 35 kg/m(2): A retrospective cohort study
por: Boonchaya‐anant, Patchaya, et al.
Publicado: (2022)

Type 2 diabetes mellitus control and atherosclerosis prevention in a non-obese rat model using duodenal-jejunal bypass
por: CHEN, XUAN, et al.
Publicado: (2014)

Absence of Role of Dietary Protein Sensing in the Metabolic Benefits of Duodenal-Jejunal Bypass in the Mouse
por: Barataud, Aude, et al.
Publicado: (2017)

Palliative Endoscopic Treatment Options in Malignancies of the Biliopancreatic System
por: Feisthammel, Jürgen, et al.
Publicado: (2014)

Duodenal-Jejunal Bypass Surgery Reverses Diabetic Phenotype and Reduces Obesity in db/db Mice
por: Liang, Yongjun, et al.
Publicado: (2017)

DUODENAL-JEJUNAL BYPASS REDUCES LIPID ACCUMULATION IN THE BROWN ADIPOSE TISSUE OF HYPOTHALAMIC OBESE RATS
por: CEGLAREK, Vanessa Marieli, et al.
Publicado: (2020)

Conversion of Roux-en-Y gastric bypass to single anastomosis duodenal ileal bypass with sleeve gastrectomy with gastrogastric jejunal bridge
por: Dib, Victor Ramos Mussa, et al.
Publicado: (2022)

Duodenal-Jejunal Bypass Surgery Stimulates the Expressions of Hepatic Sirtuin1 and 3 and Hypothalamic Sirtuin1
por: Ha, Eunyoung, et al.
Publicado: (2018)

The Use of a Hemostasis Introducer for Percutaneous Extraction of Bile Duct Stones
por: Feisthammel, Juergen, et al.
Publicado: (2012)

Duodenal and jejunal Dieulafoy’s lesions: optimal management
por: Yılmaz, Tonguç Utku, et al.
Publicado: (2017)

Effects and mechanism of duodenal-jejunal bypass and sleeve gastrectomy on GLUT2 and glucokinase in diabetic Goto–Kakizaki rats
por: Donglei, Zhou, et al.
Publicado: (2012)

Effect of duodenal-jejunal bypass surgery on glycemic control in type 2 diabetes: a randomized controlled trial
por: Petry, Tarissa Z., et al.
Publicado: (2015)

miR-200a regulates Rheb-mediated amelioration of insulin resistance after duodenal–jejunal bypass
por: Guo, W, et al.
Publicado: (2016)

Duodenal-jejunal bypass normalizes pancreatic islet proliferation rate and function but not hepatic steatosis in hypothalamic obese rats
por: Cantelli, K.R., et al.
Publicado: (2017)

The Role of Gut Microbiota in Duodenal-Jejunal Bypass Surgery-Induced Improvement of Hepatic Steatosis in HFD-Fed Rats
por: Gao, Yi, et al.
Publicado: (2021)

Alteration of Ileal lncRNAs After Duodenal–Jejunal Bypass Is Associated With Regulation of Lipid and Amino Acid Metabolism
por: Liang, Yongjun, et al.
Publicado: (2022)

Current NAFLD guidelines for risk stratification in diabetic patients have poor diagnostic discrimination
por: Blank, Valentin, et al.
Publicado: (2020)

Duodenal-jejunal bypass increases intraduodenal bile acids and upregulates duodenal SIRT1 expression in high-fat diet and streptozotocin-induced diabetic rats
por: Han, Hai-Feng, et al.
Publicado: (2022)

Single-Anastomosis Sleeve Jejunal (SAS-J) Bypass as Revisional Surgery After Primary Restrictive Bariatric Procedures
por: Sewefy, Alaa M., et al.
Publicado: (2022)

Development of the duodenal, ileal, jejunal and caecal microbiota in chickens
por: Glendinning, Laura, et al.
Publicado: (2019)

Duodenal-jejunal bypass reduces serum ceramides via inhibiting intestinal bile acid-farnesoid X receptor pathway
por: Cheng, Zhi-Qiang, et al.
Publicado: (2022)

Non-marginal jejunal ulcer perforation following Roux-en-Y gastric bypass
por: Fairweather, Luke D, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v86vicm4bgcl549bg14kvs540a